Works matching IS 0344-5704 AND VI 67 AND IP 2 AND DT 2011

Results: 29

Chemotherapeutic activity of silymarin combined with doxorubicin or paclitaxel in sensitive and multidrug-resistant colon cancer cells.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 2, p. 369, doi. 10.1007/s00280-010-1335-8

By:

Colombo, Valentina;
Lupi, Monica;
Falcetta, Francesca;
Forestieri, Daniele;
D'Incalci, Maurizio;
Ubezio, Paolo

Publication type:

Article

Pharmacokinetics in mice and metabolism in murine and human liver fractions of the putative cancer chemopreventive agents 3',4',5',5,7-pentamethoxyflavone and tricin (4',5,7-trihydroxy-3',5'-dimethoxyflavone).

Published in:

2011

By:

Cai H;
Sale S;
Britton RG;
Brown K;
Steward WP;
Gescher AJ;
Cai, Hong;
Sale, Stewart;
Britton, Robert G;
Brown, Karen;
Steward, William P;
Gescher, Andreas J

Publication type:

journal article

Population pharmacokinetics of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (Triapine®) in cancer patients.

Published in:

2011

By:

Kolesar J;
Brundage RC;
Pomplun M;
Alberti D;
Holen K;
Traynor A;
Ivy P;
Wilding G;
Kolesar, Jill;
Brundage, Richard C;
Pomplun, Marcia;
Alberti, Dona;
Holen, Kyle;
Traynor, Anne;
Ivy, Percy;
Wilding, George

Publication type:

journal article

In vitro anti-mesothelioma activity of cisplatin-gemcitabine combinations: evidence for sequence-dependent effects.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 2, p. 265, doi. 10.1007/s00280-010-1314-0

By:

Zanellato, Ilaria;
Boidi, Carla;
Lingua, Guido;
Betta, Pier-Giacomo;
Orecchia, Sara;
Monti, Elena;
Osella, Domenico

Publication type:

Article

Phase II study of S-1 in patients with gemcitabine-resistant advanced pancreatic cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 2, p. 249, doi. 10.1007/s00280-010-1311-3

By:

Sudo, Kentaro;
Yamaguchi, Taketo;
Nakamura, Kazuyoshi;
Denda, Tadamichi;
Hara, Taro;
Ishihara, Takeshi;
Yokosuka, Osamu

Publication type:

Article

Mechanistic study of BNP7787-mediated cisplatin nephroprotection: modulation of human aminopeptidase N.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 2, p. 381, doi. 10.1007/s00280-010-1333-x

By:

Hausheer, F.;
Parker, A.;
Petluru, P.;
Jair, K.;
Chen, S.;
Huang, Q.;
Chen, X.;
Ayala, P.;
Shanmugarajah, D.;
Kochat, H.

Publication type:

Article

Pharmacokinetics in mice and metabolism in murine and human liver fractions of the putative cancer chemopreventive agents 3′,4′,5′,5,7-pentamethoxyflavone and tricin (4′,5,7-trihydroxy-3′,5′-dimethoxyflavone).

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 2, p. 255, doi. 10.1007/s00280-010-1313-1

By:

Cai, Hong;
Sale, Stewart;
Britton, Robert;
Brown, Karen;
Steward, William;
Gescher, Andreas

Publication type:

Article

Pharmacokinetics and pharmacodynamics of AZD6244 (ARRY-142886) in tumor-bearing nude mice.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 2, p. 349, doi. 10.1007/s00280-010-1323-z

By:

Denton, Cathrine;
Gustafson, Daniel

Publication type:

Article

Cetuximab and circadian chronomodulated chemotherapy as salvage treatment for metastatic colorectal cancer (mCRC): safety, efficacy and improved secondary surgical resectability.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 2, p. 339, doi. 10.1007/s00280-010-1327-8

By:

Lévi, Francis;
Karaboué, Abdoulaye;
Gorden, Lee;
Innominato, Pasquale;
Saffroy, Raphael;
Giacchetti, Sylvie;
Hauteville, Dominique;
Guettier, Catherine;
Adam, René;
Bouchahda, Mohamed

Publication type:

Article

A first in human study of SB-743921, a kinesin spindle protein inhibitor, to determine pharmacokinetics, biologic effects and establish a recommended phase II dose.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 2, p. 447, doi. 10.1007/s00280-010-1346-5

By:

Holen, Kyle;
Belani, Chandra;
Wilding, George;
Ramalingam, Suresh;
Volkman, Jennifer;
Ramanathan, Ramesh;
Vasist, Lakshmi;
Bowen, Carolyn;
Hodge, Jeffrey;
Dar, Mohammed;
Ho, Peter

Publication type:

Article

Risk factors contributing to the development of carboplatin-related delayed hypersensitivity reactions in Japanese patients with gynecologic cancers.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 2, p. 415, doi. 10.1007/s00280-010-1338-5

By:

Sugimoto, Hiroko;
Iwamoto, Takuya;
Murashima, Yukiko;
Tabata, Tsutomu;
Sagawa, Norimasa;
Okuda, Masahiro

Publication type:

Article

Plasma pharmacokinetics and oral bioavailability of the 3,4,5,6-tetrahydrouridine (THU) prodrug, triacetyl-THU (taTHU), in mice.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 2, p. 421, doi. 10.1007/s00280-010-1337-6

By:

Beumer, Jan;
Eiseman, Julie;
Gilbert, Judith;
Holleran, Julianne;
Yellow-Duke, Archibong;
Clausen, Dana;
D'Argenio, David;
Ames, Matthew;
Hershberger, Pamela;
Parise, Robert;
Bai, Lihua;
Covey, Joseph;
Egorin, Merrill

Publication type:

Article

A phase I study of OSI-461 in combination with mitoxantrone in patients with advanced solid tumors potentially responsive to mitoxantrone.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 2, p. 431, doi. 10.1007/s00280-010-1328-7

By:

Resta, Lee;
Pili, Roberto;
Eisenberger, Mario;
Spitz, Avery;
King, Serina;
Porter, Jennifer;
Franke, Amy;
Boinpally, Ramesh;
Carducci, Michael;
Sweeney, Christopher

Publication type:

Article

Histone deacetylase inhibitor (HDACI) PCI-24781 potentiates cytotoxic effects of doxorubicin in bone sarcoma cells.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 2, p. 439, doi. 10.1007/s00280-010-1344-7

By:

Yang, Cao;
Choy, Edwin;
Hornicek, Francis;
Wood, Kirkham;
Schwab, Joseph;
Liu, Xianzhe;
Mankin, Henry;
Duan, Zhenfeng

Publication type:

Article

A phase I study of bevacizumab (B) in combination with everolimus (E) and erlotinib (E) in advanced cancer (BEE).

Published in:

2011

By:

Bullock, Karen;
Petros, William;
Younis, Islam;
Uronis, Hope;
Morse, Michael;
Blobe, Gerard;
Yousuf Zafar, S.;
Gockerman, Jon;
Lager, Joanne;
Truax, Roxanne;
Meadows, Kellen;
Howard, Leigh;
O'Neill, Margot;
Broadwater, Gloria;
Hurwitz, Herbert;
Bendell, Johanna

Publication type:

Report

Clinical effect of erlotinib as first-line treatment for Asian elderly patients with advanced non-small-cell lung cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 2, p. 475, doi. 10.1007/s00280-010-1450-6

By:

Xu, Xin-Hua;
Su, Jin;
Fu, Xiang-Yang;
Xue, Feng;
Huang, Qiao;
Li, Dao-Jun;
Lu, Ming-Qian

Publication type:

Article

The role of K-Ras gene mutation in TRAIL-induced apoptosis in pancreatic and lung cancer cell lines.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 2, p. 481, doi. 10.1007/s00280-010-1463-1

By:

Sahu, Ravi;
Batra, Sanjay;
Kandala, Prabodh;
Brown, Thomas;
Srivastava, Sanjay

Publication type:

Article

Population pharmacokinetics of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (Triapine) in cancer patients.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 2, p. 393, doi. 10.1007/s00280-010-1331-z

By:

Kolesar, Jill;
Brundage, Richard;
Pomplun, Marcia;
Alberti, Dona;
Holen, Kyle;
Traynor, Anne;
Ivy, Percy;
Wilding, George

Publication type:

Article

Phase I study of the combination of nedaplatin and gemcitabine in previously untreated advanced squamous cell lung cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 2, p. 325, doi. 10.1007/s00280-010-1321-1

By:

Masago, Katsuhiro;
Fujita, Shiro;
Kim, Young;
Hatachi, Yukimasa;
Fukuhara, Akiko;
Irisa, Kaoru;
Nagai, Hiroki;
Sakamori, Yuichi;
Togashi, Yosuke;
Mio, Tadashi;
Mishima, Michiaki

Publication type:

Article

Schedule treatment design and quantitative in vitro evaluation of chemotherapeutic combinations for metastatic prostate cancer therapy.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 2, p. 275, doi. 10.1007/s00280-010-1315-z

By:

Pinto, Ana;
Ângelo, Susana;
Moreira, João;
Simões, Sérgio

Publication type:

Article

Serum levels of surfactant protein D predict the anti-tumor activity of gefitinib in patients with advanced non-small cell lung cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 2, p. 331, doi. 10.1007/s00280-010-1325-x

By:

Yamaguchi, Hiroyuki;
Soda, Hiroshi;
Nakamura, Yoichi;
Takasu, Mineyo;
Tomonaga, Nanae;
Nakano, Hirofumi;
Doi, Seiji;
Nakatomi, Katsumi;
Nagashima, Seiji;
Takatani, Hiroshi;
Fukuda, Minoru;
Hayashi, Tomayoshi;
Tsukamoto, Kazuhiro;
Kohno, Shigeru

Publication type:

Article

Announcement.

Published in:: Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 2, p. 247, doi. 10.1007/s00280-011-1564-5
Publication type:: Article

A phase I/II trial of the oral antiangiogenic agent TSU-68 in patients with advanced hepatocellular carcinoma.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 2, p. 315, doi. 10.1007/s00280-010-1320-2

By:

Kanai, Fumihiko;
Yoshida, Haruhiko;
Tateishi, Ryosuke;
Sato, Shinpei;
Kawabe, Takao;
Obi, Shuntaro;
Kondo, Yuji;
Taniguchi, Makoto;
Tagawa, Kazumi;
Ikeda, Masafumi;
Morizane, Chigusa;
Okusaka, Takuji;
Arioka, Hitoshi;
Shiina, Shuichiro;
Omata, Masao

Publication type:

Article

Phase I and pharmacokinetic study of lonafarnib, SCH 66336, using a 2-week on, 2-week off schedule in patients with advanced solid tumors.

Published in:

2011

By:

Castaneda, Carlos;
Meadows, Kellen;
Truax, Roxanne;
Morse, Michael;
Kaufmann, Scott;
Petros, William;
Zhu, Yali;
Statkevich, Paul;
Cutler, David;
Hurwitz, Herbert

Publication type:

Report

Second-line chemotherapy with Capecitabine (Xeloda) and Docetaxel (Taxotere) in previously treated, unresectable adenocarcinoma of pancreas: the final results of a phase II trial.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 2, p. 361, doi. 10.1007/s00280-010-1329-6

By:

Katopodis, Ourania;
Polyzos, Aris;
Kentepozidis, Nikolaos;
Giassas, Stylianos;
Rovithi, Maria;
Bozionelou, Vasiliki;
Kalbakis, Kostas;
Vamvakas, Lambros;
Mavroudis, Dimitris;
Georgoulias, Vassilis

Publication type:

Article

Combination effects of platinum drugs and N, N diethylnorspermine on spermidine/spermine N-acetyltransferase, polyamines and growth inhibition in A2780 human ovarian carcinoma cells and their oxaliplatin and cisplatin-resistant variants.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 2, p. 401, doi. 10.1007/s00280-010-1334-9

By:

Tummala, Ramakumar;
Diegelman, Paula;
Hector, Suzanne;
Kramer, Debora;
Clark, Kimberly;
Zagst, Patricia;
Fetterly, Gerald;
Porter, Carl;
Pendyala, Lakshmi

Publication type:

Article

Tamoxifen and raloxifene suppress the proliferation of estrogen receptor-negative cells through inhibition of glutamine uptake.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 2, p. 285, doi. 10.1007/s00280-010-1316-y

By:

Todorova, Valentina;
Kaufmann, Yihong;
Luo, Shaoke;
Suzanne Klimberg, V.

Publication type:

Article

Phase I dose escalation study of MK-0457, a novel Aurora kinase inhibitor, in adult patients with advanced solid tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 2, p. 305, doi. 10.1007/s00280-010-1318-9

By:

Traynor, Anne;
Hewitt, Maureen;
Liu, Glenn;
Flaherty, Keith;
Clark, Jason;
Freedman, Steven;
Scott, Boyd;
Leighton, Ann;
Watson, Patricia;
Zhao, Baiteng;
O'Dwyer, Peter;
Wilding, George

Publication type:

Article

A novel bis-indole destabilizes microtubules and displays potent in vitro and in vivo antitumor activity in prostate cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 2, p. 293, doi. 10.1007/s00280-010-1319-8

By:

Ahn, Sunjoo;
Hwang, Dong;
Barrett, Christina;
Yang, Jun;
Duke, Charles;
Miller, Duane;
Dalton, James

Publication type:

Article